HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.27
-0.09 (-0.63%)
At close: Oct 26, 2026, 4:00 PM EDT
14.34
+0.07 (0.46%)
After-hours: Oct 26, 2026, 4:10 PM EDT
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.44 billion as of October 26, 2026. Its market cap has decreased by 7.55% in one year.
Market Cap
2.44B
Enterprise Value
1.16B
1-Year Change
-7.55%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.44B, an increase of 52.56%. That is a compound annual growth rate of 4.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 2.51B | 7.75% |
| Dec 31, 2025 | 2.33B | -7.42% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
| Mar 17, 2016 | 1.60B | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Liquidia | 3.82B |
| Regencell Bioscience Holdings | 3.80B |
| Amylyx Pharmaceuticals | 3.41B |
| Bausch Health Companies | 2.41B |
| Supernus Pharmaceuticals | 2.37B |
| Prestige Consumer Healthcare | 2.26B |
| Perrigo Company | 2.21B |
| Trulieve Cannabis | 2.01B |